Elementis PLC Unsponsored ADR AI Stock Analysis
Want to see ELMTY full AI Analyst Report?
Elementis PLC Unsponsored ADR (ELMTY) AI Stock Analysis
Elementis PLC Unsponsored ADR
(Other OTC:ELMTY)
Overall score is driven primarily by stable-to-improving fundamentals at the operating level and consistently positive cash generation, but constrained by ongoing net losses and a declining revenue trend. Technicals are mildly supportive but not strong, and valuation is reasonable with a modest dividend yield.
Elementis PLC Unsponsored ADR (ELMTY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.32B
- Dividend Yield
- 2.31%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 19.6
- Beta (1Y)
- 0.70
- Revenue Growth
- -8.97%
- EPS Growth
- ―
- Country
- US
- Employees
- 989
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Elementis PLC Unsponsored ADR Business Overview & Revenue Model
Company Description
Elementis plc functions as a global producer of specialty chemicals, maintaining operations across the United Kingdom, North America, other European regions, and various international markets. Its business activities are structured into four key divi...
How the Company Makes Money
Elementis makes money primarily by selling specialty chemical additives and formulated ingredients to business customers (B2B). Revenue is generated from (1) product sales into its key end markets—most notably coatings and personal care—where its add...
Elementis PLC Unsponsored ADR Earnings Call Summary
The call emphasized strong profitability, margin expansion, strategic portfolio simplification, innovation momentum and meaningful cost-savings delivery, while acknowledging softer top-line trends in Coatings, working capital and cash-flow pressures and remaining operational fixes at St. Louis. Overall, management presented a confident, execution-focused outlook with clear medium-term targets (mid-single-digit revenue growth, >23% operating margin, >90% three-year cash conversion), supported by sustainability and safety progress and disciplined bolt-on M&A.
Q4-2025 Updates
Positive Updates
Negative Updates
Company Guidance
The company’s guidance under the Elevate Elementis strategy targets mid‑single‑digit revenue growth, operating margins of >23%, 3‑year operating cash conversion >90% and ROCE (ex‑goodwill) >30%; for 2026 management flags CapEx of 4–5% of revenue, a small working‑capital outflow (no factoring), and expects to be circa 1x net debt/EBITDA organically by end‑2026 (after distributing net proceeds from the pharma sale to shareholders). For context, 2025 headlines (the base year) were revenue $597.5m (‑1.9% cc), adjusted operating profit $126.7m (margin 21.2%, +150bps), adjusted EPS $0.137 (+14.2%), free cash flow $41m and adjusted operating cash flow $104.7m, with net debt $185.4m (1.3x) after returning $79.1m to shareholders (buyback + dividends) and cancelling ~4% of share capital. Management also expects further self‑help savings (delivered $18m + $6m from the new program, $4m remaining to end‑2026), to raise R&D from 2% to 3% of revenue (50% increase), to push innovation sales toward a 20% target (16.4% in 2025), to improve service metrics (On‑Time‑In‑Full half‑way to a 20% uplift) and to continue operational improvements (St. Louis debottlenecking +20% since H1, ~2/3 of the 30% opportunity).
Elementis PLC Unsponsored ADR Financial Statement Overview
Summary
Operating performance improved materially (EBIT margin ~17.5%, EBITDA margin ~22.9%) and gross margin remained strong (~46.6%), while operating and free cash flow stayed positive (~$75M OCF; ~$53M FCF). Offsetting this, revenue declined (~-9.8% in 2025) and net income remained negative (net margin ~-7.6%), keeping ROE negative and limiting balance-sheet strengthening through retained earnings.
Income Statement
56NeutralBalance Sheet
63PositiveCash Flow
61Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 606.65M | 598.90M | 738.30M | 713.40M | 736.40M | 709.40M |
| Gross Profit | 294.76M | 279.15M | 338.00M | 284.30M | 298.90M | 289.00M |
| EBITDA | 146.34M | 135.74M | 3.40M | 114.20M | 151.86M | 85.60M |
| Net Income | 74.02M | -45.61M | -47.80M | 26.50M | -51.10M | 2.50M |
Balance Sheet | ||||||
| Total Assets | 1.14B | 1.11B | 1.31B | 1.51B | 1.63B | 1.84B |
| Cash, Cash Equivalents and Short-Term Investments | 86.20M | 54.60M | 59.90M | 65.80M | 54.90M | 84.60M |
| Total Debt | 264.50M | 256.60M | 253.90M | 300.90M | 453.70M | 522.70M |
| Total Liabilities | 472.30M | 470.70M | 551.40M | 664.10M | 843.10M | 935.60M |
| Stockholders Equity | 662.70M | 643.90M | 757.00M | 847.30M | 783.90M | 901.00M |
Cash Flow | ||||||
| Free Cash Flow | 38.39M | 53.02M | 62.20M | 38.60M | 29.90M | 13.60M |
| Operating Cash Flow | 64.96M | 75.38M | 100.00M | 76.80M | 77.00M | 66.70M |
| Investing Cash Flow | -21.02M | -8.32M | -37.50M | 101.10M | -46.90M | -65.00M |
| Financing Cash Flow | -18.81M | -82.69M | -59.80M | -168.00M | -57.80M | -25.30M |
Elementis PLC Unsponsored ADR Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ELMTY, the sentiment is Positive. The current price of 10.18 is above the 20-day moving average (MA) of 10.05, above the 50-day MA of 9.67, and above the 200-day MA of 8.82, indicating a bullish trend. The MACD of 0.17 indicates Positive momentum. The RSI at 57.15 is Neutral, neither overbought nor oversold. The STOCH value of 28.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ELMTY.
Elementis PLC Unsponsored ADR Peers Comparison
Overall Rating
IOSP72Outperform
ASH61Neutral
ELMTY60Neutral
CBT58Neutral
SCL55Neutral
MTX46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $1.98B | 14.15 | 10.42% | 2.23% | 4.73% | ― | |
| 61Neutral | $3.50B | 849.67 | 0.21% | 2.18% | 2.08% | ― | |
| 60Neutral | $1.43B | 19.63 | 11.29% | 2.31% | -8.97% | ― | |
| 58Neutral | $3.69B | 17.63 | 13.35% | 2.57% | 0.83% | -33.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | $1.51B | 349.37 | 0.36% | 2.38% | 10.02% | -90.50% | |
| 46Neutral | $1.91B | -28.13 | -4.12% | 0.80% | 4.76% | -19991.67% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ELMTY | Elementis PLC Unsponsored ADR | 10.18 | 2.10 | 26.01% | |
| ASH | Ashland Global Holdings, Inc. | 76.47 | 28.22 | 58.49% | |
| CBT | Cabot Corp | 71.92 | 13.88 | 23.92% | |
| IOSP | Innospec | 80.39 | 9.03 | 12.65% | |
| MTX | Minerals Technologies | 61.33 | 4.49 | 7.90% | |
| SCL | Stepan Company | 66.38 | 24.98 | 60.33% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 24, 2026
